Insufficient scRNA-seq data for expression of NAGS at single-cell level.
Insufficient scRNA-seq data for expression of NAGS at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 660.49 | 653 / 653 | 89% | 17.49 | 541 / 605 |
liver | 100% | 3251.11 | 226 / 226 | 89% | 33.71 | 362 / 406 |
lung | 96% | 277.80 | 555 / 578 | 91% | 7.60 | 1046 / 1155 |
skin | 99% | 431.90 | 1795 / 1809 | 76% | 3.63 | 359 / 472 |
kidney | 100% | 627.18 | 89 / 89 | 75% | 5.80 | 672 / 901 |
uterus | 86% | 111.20 | 146 / 170 | 82% | 5.96 | 378 / 459 |
breast | 90% | 231.60 | 415 / 459 | 77% | 7.27 | 864 / 1118 |
esophagus | 82% | 111.93 | 1182 / 1445 | 83% | 6.33 | 151 / 183 |
ovary | 81% | 89.46 | 145 / 180 | 74% | 3.48 | 317 / 430 |
prostate | 98% | 194.96 | 240 / 245 | 56% | 1.88 | 281 / 502 |
bladder | 71% | 66.52 | 15 / 21 | 80% | 5.75 | 403 / 504 |
intestine | 69% | 336.86 | 669 / 966 | 81% | 6.48 | 428 / 527 |
stomach | 55% | 42.39 | 199 / 359 | 77% | 5.57 | 220 / 286 |
brain | 66% | 81.35 | 1750 / 2642 | 64% | 2.32 | 449 / 705 |
pancreas | 26% | 19.06 | 85 / 328 | 90% | 8.35 | 161 / 178 |
adrenal gland | 66% | 89.04 | 171 / 258 | 34% | 2.58 | 78 / 230 |
tonsil | 0% | 0 | 0 / 0 | 91% | 6.30 | 41 / 45 |
spleen | 90% | 82.64 | 216 / 241 | 0% | 0 | 0 / 0 |
adipose | 77% | 107.40 | 923 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 70% | 2.55 | 56 / 80 |
peripheral blood | 60% | 53.39 | 562 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 59% | 1.51 | 17 / 29 |
heart | 52% | 64.43 | 445 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 47% | 40.51 | 625 / 1335 | 0% | 0 | 0 / 0 |
muscle | 9% | 6.63 | 70 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006536 | Biological process | glutamate metabolic process |
GO_0000050 | Biological process | urea cycle |
GO_0006526 | Biological process | arginine biosynthetic process |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0004042 | Molecular function | acetyl-CoA:L-glutamate N-acetyltransferase activity |
GO_0103045 | Molecular function | methione N-acyltransferase activity |
Gene name | NAGS |
Protein name | N-acetylglutamate synthase N-acetylglutamate synthase, mitochondrial (EC 2.3.1.1) (Amino-acid acetyltransferase) [Cleaved into: N-acetylglutamate synthase long form; N-acetylglutamate synthase short form; N-acetylglutamate synthase conserved domain form] NAGS protein (cDNA FLJ54171, highly similar to N-acetylglutamate synthase, mitochondrial) |
Synonyms | |
Description | FUNCTION: Plays a role in the regulation of ureagenesis by producing the essential cofactor N-acetylglutamate (NAG), thus modulating carbamoylphosphate synthase I (CPS1) activity. . |
Accessions | K7EK11 ENST00000589767.1 ENST00000293404.8 Q8N159 Q2NKP2 |